MedPlanner has launched HEMI Health and AskHEMI, expanding its clinical AI offering in the UK, Malaysia and global consumer markets.
HEMI Health is aimed at clinicians and is available in Malaysia and the UK. AskHEMI is a free app for patients, carers and the public on iOS and Android, with multilingual support. Both products run on the company's HEMI, or Health Medical Intelligence, engine and join HEMI Teams, MedPlanner's hospital clinical coordination platform.
The launch marks a broader push by the Kuala Lumpur-based group to cover more of the patient pathway, from hospital care coordination to consultation notes and follow-up support at home. It has also set up HEMI in London as an international distribution arm for commercial and partnership activity across the UK, Europe and other markets.
Expanded platform
HEMI Health is positioned as an AI clinical assistant designed to reduce doctors' administrative load. It includes medical scribing, documentation of clinical reasoning, decision support, and tools intended to help clinicians respond to professional complaints and maintain records for review.
That reflects two longstanding issues in healthcare systems: the volume of clinical paperwork and doctors' concerns about legal and regulatory scrutiny. Suppliers of AI tools for healthcare have increasingly targeted both areas as health services seek to ease staff pressures and standardise records.
AskHEMI, by contrast, is a patient-facing service built to support people outside formal appointments. The app can help users manage chronic conditions, set medication reminders and answer questions after consultations. It is also designed to operate in multiple languages.
The app is built on a clinical knowledge base rather than information drawn from the open web. MedPlanner also said the system is designed to reflect local health systems and escalate when appropriate, though it did not provide details on how that process works in different jurisdictions.
Clinical origins
MedPlanner was founded by Dr Ezam Mat Ali, an NHS-trained Consultant Paediatrician. The platform was shaped by problems he encountered in clinical practice, including fragmented systems, paperwork burdens and gaps in support for patients after appointments.
"As a clinician, I have seen first-hand how fragmented systems fail the people they are meant to serve. Doctors are buried in paperwork. Patients leave appointments confused and unsupported. MedPlanner exists because we believed there was a better way. One engine. One connected intelligence. Addressing the full journey from hospital ward to patient at home," said Dr Ezam Mat Ali, Founder and Chief Executive Officer, MedPlanner.
His background also includes work as a Medicolegal Adviser to the Medical Protection Society, a detail that helps explain MedPlanner's emphasis on documentation and complaint-response tools within HEMI Health. The company argues that this part of the market remains underserved by software focused mainly on transcription.
"Other companies build AI products. We built an engine. HEMI Health does not just scribe. It documents clinical reasoning, supports professional self-protection, and builds a contemporaneous record that stands up in any review. That is not a feature. That is a foundation," added Ali.
UK expansion
The UK is a notable target market. The NHS has been exploring the use of AI in administrative and clinical settings, while a growing number of suppliers compete to offer note-taking tools, workflow software and patient support systems to trusts and clinicians.
By making HEMI Health available in the UK and establishing a London entity, MedPlanner appears to be seeking a foothold in a market where demand for productivity tools is high, but scrutiny around safety, governance and data handling is also intense. The company said its common compliance framework meets GDPR and NHS standards.
At the same time, the patient app gives MedPlanner a route into a broader international user base beyond hospitals and doctors. Free distribution through mobile app stores can help build scale, although patient-facing health AI products face their own challenges around trust, reliability and clinical oversight.
Shared engine
MedPlanner describes itself as a clinician-led health technology company and says its products were designed in Southeast Asia for multilingual use across different clinical cultures. That regional origin may offer an advantage in markets where healthcare providers and patients need tools that can operate across multiple languages, rather than only in English.
All three products are connected through the same AI engine, with HEMI Teams handling hospital clinical care coordination, HEMI Health supporting clinician documentation, and AskHEMI serving patients and carers between appointments.
AskHEMI is available globally as a free download on iOS and Android, with multilingual support.